An interventional study of Fortini formula and Standard Nutritional Care in Single-ventricle, sponsored by Driscoll Children's Hospital. Recruiting at 1 site in United States. Open to participants aged 0 Months to 6 Months. Per ClinicalTrials.gov, last updated 2026-05-13.
Sponsored by Driscoll Children's Hospital · Not applicable, Interventional, and Supportive care
This study is testing whether a special formula called Fortini, which is a high-calorie, low osmolality formula can help high-risk babies with single ventricle physiology grow better after their initial Stage 1 surgical palliation. These babies often struggle to gain weight, which can lead to more health problems before their next surgery.
After their first heart surgery, but prior to discharge, babies will be randomly placed into two groups. One group will get Fortini formula when they leave the hospital, and the other group will get the standard of care high-calorie formula. The primary goal is to see if Fortini helps babies grow better by the time they are ready for their second surgery.
The study will also check if the babies tolerate the formula well, how much they eat, how often they are re-admitted to the hospital, and how their caregivers feel about feeding. The babies will be followed for up to 4 months, until they return for their next surgery. About 100 infants are expected to join the study at Driscoll Children's Hospital.
This research may help improve nutrition care for infants with complex heart conditions and reduce stress for their families.
Infants with single ventricle physiology are among the highest-risk pediatric cardiac patients, particularly during the interstage period between Stage 1 and Stage 2 surgical palliation. Suboptimal growth during this time is a well-established predictor of increased morbidity, prolonged hospitalization, and adverse surgical outcomes. Despite advances in interstage monitoring and nutritional support, many infants fail to achieve adequate weight gain, and caregiver burden related to complex feeding regimens remains high.
Current feeding strategies often require fortification to 24-30 kcal/oz using breast milk or standard infant formulas (including hydrolyzed formulas), which may necessitate increased volume or complex mixing that is difficult to sustain at home. Fortini, a commercially available formula providing 30 kcal/oz, is commonly used in older children with failure to thrive or feeding intolerance. It offers the theoretical benefit of providing higher caloric density in a lower volume, which may be advantageous in infants with single ventricle physiology, who often have limited volume tolerance and high metabolic demands.
Preliminary experience and retrospective studies in infants with congenital heart disease suggest that increasing caloric density without increasing volume may support improved weight gain. However, Fortini's use in infants under 6 months-especially those with single ventricle physiology-remains unstudied in a prospective, controlled manner. No data currently exist on its safety, efficacy, or impact on caregiver experience in this vulnerable population. This study seeks to address this gap by examining whether introducing Fortini formula at discharge improves growth and caregiver-reported feeding outcomes in single ventricle infants, compared to current standard nutritional care.
DATA ANALYSIS PLAN:
POWER ANALYSIS:
Based on preliminary data and existing literature:
To detect a clinically meaningful difference of 0.4 in WAZ:
CONFOUNDING VARIABLES:
Key anticipated confounders:
Plan to address:
HANDLING MISSING DATA AND OUTLIERS:
Missing outcome data will be assessed for randomness
Outliers (e.g. extreme WAZ changes or caloric intake values) will be:
86 studies on the registry are indexed under Univentricular Heart; 22 are open to participants now.
This study's planned enrollment of 100 is above the median of 28 across 44 interventional studies indexed under Univentricular Heart.
Browse Univentricular Heart studies →Driscoll Children's Hospital is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Fortini, a commercially available formula providing 30 kcal/oz
Other: Fortini formula
Standard infant formulas (including hydrolyzed formulas) fortification to 24-30 kcal/oz
Other: Standard Nutritional Care
Fortini, a commercially available formula providing 30 kcal/oz, is commonly used in older children with failure to thrive or feeding intolerance. It offers the theoretical benefit of providing higher caloric density in a lower volume, which may be advantageous in infants with single ventricle physiology, who often have limited volume tolerance and high metabolic demands.
Standard infant formulas (including hydrolyzed formulas) fortification to 24-30 kcal/oz
Change in weight-for-age Z-score (WAZ)
Change in weight-for-age Z-score (WAZ) from hospital discharge after Stage 1 surgical palliation to Stage 2 surgical evaluation, which is typically 4-6 months after discharge or between 6-9 months of age
Time frame: 4-6 months
Incidence of feeding intolerance
Incidence of feeding intolerance (e.g., emesis, diarrhea, constipation requiring change in formula)
Time frame: 4-6 months
Daily caloric intake
Average daily caloric intake (kcal/kg/day) during interstage period (4-6 months after hospital discharge)
Time frame: 4-6 months
Unplanned readmissions
Number of unplanned readmissions related to feeding or failure to thrive within the 4-6 months after discharge
Time frame: 4-6 months
Caregiver-reported feeding stress
Caregiver-reported feeding stress (measured via a validated survey/score on a scale of 1-10 where 1 is no stress and 10 is the most stress)
Time frame: 4-6 months
Proportion of infants reaching target WAZ
Proportion of infants reaching target WAZ (\> -1) by Stage 2 or 4-6 months after hospital discharge
Time frame: 4-6 months
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Driscoll Children's Hospital